- £49.26m
- £52.32m
- $29.49m
- 46
- 18
- 92
- 50
REG - Tissue Regenix Group - Half-Year Trading Update
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 24/06/2024
AnnouncementREG - Tissue Regenix Group - Exercise of Options, Director Dealing and TVR
AnnouncementREG - Tissue Regenix Group - Building purchase
AnnouncementREG - Tissue Regenix Group - Result of AGM
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - Tissue Regenix Group - Final results for the year ended 31 December 2023
AnnouncementREG - Tissue Regenix Group - Notice of Results
AnnouncementRCS - Tissue Regenix Group - First EU shipment & new distributor agreements
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - Tissue Regenix Group - Trading update for 2023
AnnouncementREG - Tissue Regenix Group - 2023 LTIP Grant
AnnouncementREG - Tissue Regenix Group - Holding(s) in Company
AnnouncementREG - Tissue Regenix Group - HPRA approval & distribution agreement in Spain
AnnouncementREG - Tissue Regenix Group - Director/PDMR Shareholding
AnnouncementREG - AIM - AIM Notice - 06/09/2023
AnnouncementREG - Tissue Regenix Group - New sports medicine product launch
Announcement